Literature DB >> 8274731

Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells.

R A Steinman1, D J Tweardy.   

Abstract

The identification of early markers of myeloid differentiation can facilitate an understanding of how differentiation is arrested in leukemogenesis. Using murine bone marrow and the granulocyte-precusor cell line 32Dc13, we show that message for the granulocyte colony-stimulating factor receptor (G-CSFR) is upregulated by G-CSF in an immediate early fashion that is specific to the differentiation pathway and is antagonized by interleukin-3. We further show that G-CSFR message is superinduced by cycloheximide and that these patterns of regulation are altered in leukemic cell lines. In particular, the v-abl oncogene product supresses both ligand-mediated upregulation and superinduction of the G-CSFR gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8274731

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.

Authors:  Ivar Østby; Leiv S Rusten; Gunnar Kvalheim; Per Grøttum
Journal:  J Math Biol       Date:  2003-04-23       Impact factor: 2.259

2.  G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Authors:  Saurabh Agarwal; Anna Lakoma; Zaowen Chen; John Hicks; Leonid S Metelitsa; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2015-04-23       Impact factor: 12.701

3.  Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients.

Authors:  K Terashi; M Oka; S Ohdo; T Furukubo; C Ikeda; M Fukuda; H Soda; S Higuchi; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Lactobacillus rhamnosus GR-1 stimulates colony-stimulating factor 3 (granulocyte) (CSF3) output in placental trophoblast cells in a fetal sex-dependent manner.

Authors:  Maryam Yeganegi; Chiashan G Leung; Andrew Martins; Sung O Kim; Gregor Reid; John R G Challis; Alan D Bocking
Journal:  Biol Reprod       Date:  2010-09-01       Impact factor: 4.285

5.  Myeloblastin is a granulocyte colony-stimulating factor-responsive gene conferring factor-independent growth to hematopoietic cells.

Authors:  P G Lutz; C Moog-Lutz; E Coumau-Gatbois; L Kobari; Y Di Gioia; Y E Cayre
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells.

Authors:  Fang Li; Danielle Y Hu; Shu Liu; Sunila Mahavadi; William Yen; Karnam S Murthy; Kamel Khalili; Wenhui Hu
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-29       Impact factor: 4.249

7.  Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats.

Authors:  M Scholz; C Engel; D Apt; S L Sankar; E Goldstein; M Loeffler
Journal:  Cell Prolif       Date:  2009-09-24       Impact factor: 6.831

8.  TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.

Authors:  D Perrotti; S Bonatti; R Trotta; R Martinez; T Skorski; P Salomoni; E Grassilli; R V Lozzo; D R Cooper; B Calabretta
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

9.  A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia.

Authors:  M Scholz; M Ackermann; C Engel; F Emmrich; M Loeffler; M Kamprad
Journal:  Cell Prolif       Date:  2009-08-17       Impact factor: 6.831

10.  IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability.

Authors:  Jason Ernst; Louis Ghanem; Ziv Bar-Joseph; Michael McNamara; Jason Brown; Richard A Steinman
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.